Graduate Winners of the Entrepreneurship and Innovation student competitions for 2010-2011
March 28, 2011
First Place:
Trial Guardian / Hanna Farah
Contract Research Organizations (CROs) often conduct clinical trials to assess the safety and efficacy of a drug in human subjects. CROs are required to provide assurance that the data and reported results are credible and accurate under the Good Clinical Practices (GCPs) international ethical and scientific quality standard. CROs have expressed the need for a solution to verify participant’s eligibility to clinical trials to prevent concurrent or inappropriate enrolment. We present Trial Guardian, a web-based solution with unique privacy guarantees for the CROs participants’ data. Our product is feature rich providing more functionality and better accuracy than our sole competitor.
Second Place:
RFIP (Radio Frequency Identification for Pharmaceuticals) / Alexey Borisenko, Lukash Monczak, Ovidiu Draghici, Daniel Shapiro (absent), Jonathan Parri
RFIP (Radio Frequency Identification for Pharmaceuticals) is a new high-tech suite of products focused on pharmaceutical manufacturing processes with integration of radio technology into electronic healthcare delivery systems. Our proprietary solutions are geared towards customers in the pharmaceutical industry, with a focus on high value-added products vulnerable to counterfeiting or adverse response litigation. RFIP exemplifies current needs for pharmaceutical authentication,
Third Place:
Target Life / Nicolas Ellaham, Karen Soueidan
TargetLife is a start-up venture created by a determined and passionate team of individuals with valuable knowledge in technology and dedication to the business. As biomedical engineers, the owners, Mr. Nicolas Ellaham and Ms. Karen Soueidan, have put a lot of thought into the foundation of this endeavor that could potentially improve the quality of life of many. By focusing on high quality products, reliable customer service, creative promotion strategy and continuous operational improvement, our journey is projected to break even at the very beginning of the second year.
Go Back